Literature DB >> 9425251

Azithromycin and clarithromycin inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells.

W S Champney1, R Burdine.   

Abstract

The ID50 values for azithromycin and clarithromycin inhibition of translation and of 50S assembly in Staphylococcus aureus cells have been measured. For clarithromycin, 50% inhibition of growth occurred at 0.075 microg/ml, and the effects on translation and 50S formation were equivalent at 0.15 microg/ml. The inhibition of these processes by azithromycin was less effective, with an ID50 of 2.5 microg/ml for growth and 5 microg/ml for inhibition of translation and 50S formation. The additive effects of each of these drugs on translation and 50S formation account quantitatively for their observed influence on cellular growth rates. In macrolide-treated cells, there was also a direct relationship between the loss of ribosomal RNA from the 50S subunit and its accumulation as oligoribonucleotides. These results are compared with the previously described effects of erythromycin on these same processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9425251     DOI: 10.1007/s002849900290

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  10 in total

1.  30S ribosomal subunit assembly is a target for inhibition by aminoglycosides in Escherichia coli.

Authors:  Roopal Mehta; W Scott Champney
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Chemical modulators of ribosome biogenesis as biological probes.

Authors:  Jonathan M Stokes; Eric D Brown
Journal:  Nat Chem Biol       Date:  2015-11-17       Impact factor: 15.040

Review 3.  Inhibition of bacterial ribosome assembly: a suitable drug target?

Authors:  Bruce A Maguire
Journal:  Microbiol Mol Biol Rev       Date:  2009-03       Impact factor: 11.056

4.  Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.

Authors:  W Scott Champney; Ward K Rodgers
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

5.  Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus.

Authors:  M Joyce Nirmala; Amitava Mukherjee; N Chandrasekaran
Journal:  AAPS PharmSciTech       Date:  2013-06-26       Impact factor: 3.246

6.  Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.

Authors:  W S Champney; C L Tober
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.

Authors:  W S Champney; C L Tober
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

Review 8.  Mechanism of action, resistance, synergism, and clinical implications of azithromycin.

Authors:  Mohsen Heidary; Ahmad Ebrahimi Samangani; Abolfazl Kargari; Aliakbar Kiani Nejad; Ilya Yashmi; Moloudsadat Motahar; Elahe Taki; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

9.  Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat.

Authors:  Giuseppe Pasquale Varano; Vincenzo Parisi; Annagrazia Adornetto; Federica Cavaliere; Diana Amantea; Carlo Nucci; Maria Tiziana Corasaniti; Luigi Antonio Morrone; Giacinto Bagetta; Rossella Russo
Journal:  Mol Vis       Date:  2017-12-11       Impact factor: 2.367

10.  Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.

Authors:  Bei Zhang; Timothy J Kopper; Xiaodong Liu; Zheng Cui; Steven G Van Lanen; John C Gensel
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.